Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

US Patent 11759518 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
HSP70-derived peptide, pharmaceutical composition for treating or preventing can2025
Anti-GPC3 antibody2024
Universal anti-tag chimeric antigen receptor-expressing t cells and methods of t2024
Immunocompetent cell and expression vector expressing regulatory factors of immu2024
Anti-GPC3 antibody2023
Enhancer for T-cells or B-cells having memory function, malignant tumor recurren2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention2023
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention2023
Composition comprising poly I:C and LAG-3-IGG fusion protein2022
Composition comprising poly I:C and LAG-3-IGG fusion protein2022
Composition comprising poly I:C and LAG-3-IGG fusion protein2022